Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

34.78 +0.69 (+2.04%)
Streaming Delayed Price Updated: 12:57 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AtriCure, Inc. - Common Stock

< Previous 1 2 3 Next >
AtriCure (ATRC) Q3 2025 Earnings Call Transcript
AtriCure (ATRC) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
AtriCure Inc (NASDAQ:ATRC) Surpasses Q3 2025 Earnings Estimates and Raises Full-Year Outlook
AtriCure's Q3 2025 earnings beat expectations with a narrowed loss and strong revenue growth. The medical device firm also raised its full-year financial outlook. 
Via Chartmill
Topics Earnings
Earnings Scheduled For October 29, 2025
 
Via Benzinga
AtriCure (ATRC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
AtriCure (ATRC) Q2 Revenue Jumps 17%
Via The Motley Fool
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Earnings Scheduled For July 29, 2025
 
Via Benzinga
Earnings Scheduled For April 29, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
What's going on in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
14 Analysts Assess AtriCure: What You Need To Know
 
Via Benzinga
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
AtriCure Earnings Preview
 
Via Benzinga
Earnings Scheduled For February 12, 2025
 
Via Benzinga
Expert Outlook: AtriCure Through The Eyes Of 5 Analysts
 
Via Benzinga
11 Analysts Have This To Say About AtriCure
 
Via Benzinga
Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings)
 
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
 
Via Benzinga
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Navigating 6 Analyst Ratings For AtriCure
 
Via Benzinga
Analyst Ratings For AtriCure
 
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Key Takeaways From AtriCure Analyst Ratings
 
Via Benzinga
ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024
ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.